home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

2nd Annual Oncology Clinical Development Congress 2013

 
  February 04, 2013  
     
 
Oxford Global Conferences, Manchester
14th&15th October 2013


The Event

In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 50 speakers will present a full conference programme covering the topics outlined below.

Day 1 – Clinical Development

  • Establishing acceptable endpoints
  • Developing targeted therapies
  • Strategic partnerships
  • Innovation in clinical imaging
  • Co-development of combined therapies
  • Avoiding late-stage failures

Day 2 – Clinical Trials

  • Increasing efficiency through trial design
  • Trials in emerging markets
  • Comparative trials
  • Regulation and compliance
  • Adaptive trial designs
  • Clinical outsourcing
  • Patient recruitment and retention
  • CRO relationship management
  • Operational challenges
 
 
Organized by: Oxford Global Conferences
Invited Speakers:
  • Philip Arlen
    President & CEO, Precision Biologics
  • Marnix L Bosch
    Chief Technical Officer, Northwest Biotherapeutics, Inc.
  • Qinhua Cindy Ru
    Clinical Trial Head, Novartis
  • Robert Coleman
    Professor of Medical Oncology and Associate Director of the National Cancer Research Network
  • Silvia Corretge
    Clinical Research Oncology, Boehringer Ingelheim
  • Laura Cove-Smith
    University of Manchester
  • Birgit Gaschler-Markefski
    Head of German Clinical Biostatistics Group Oncology, Boehringer Ingelheim Pharma GmbH&Co. KG
  • Christopher Hart
    Clinical Information Science Director, AstraZeneca
  • Victoria John
    Head of Clinical Partnerships, Cancer Research UK
  • Prash Krishna
    Director - Oncology, Clinical Development, Eisai UK
  • Frédéric Levy
    Associate Director, Research & Evaluation, Debiopharm
  • Howard Mellor
    Drug Safety Scientist, AstraZeneca
  • Tsveta Milenkova
    Senior Research Physician, AstraZeneca
  • Robert Morgan
    SVP Regulator Affairs, Ziopharm
  • Patrick Nealon
    Senior Director Clinical Operations, Millennium
  • Martin Picard
    Senior Medical Director, Head Cilengitide, Global Clinical Development Unit Oncology, Merck
  • Ruth Plummer
    Clinical Professor of Experimental Cancer Medicine, Newcastle University
  • Justine Reise
    Senior Clinical Trials Manager-Oncology, Imperial College London
  • Senior Representative
    Northwest Biotherapeutics
  • Marie Anne Stager
    Director, Clinical Operations, Seattle Genetics
  • Eric Towler
    Director, Global Project Management & Leadership, Daiichi Sankyo
  • Chris Twelves
    Deputy Director, Cancer Research UK Clinical Centre, Leeds
  • Helgi Van De Velde
    Senior Director Oncology Clinical Research, Johnson & Johnson
  • Bob Wellings
    Clinical Biomarker Scientist, AstraZeneca
 
Deadline for Abstracts: NA
 
Registration: For more information and to register: http://www.oncologyclinicaldevelopment-congress.com/download-agenda/
E-mail: d.meredith@oxfordglobal.co.uk
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.